vs
Side-by-side financial comparison of AMERISAFE INC (AMSF) and Evolus, Inc. (EOLS). Click either name above to swap in a different company.
Evolus, Inc. is the larger business by last-quarter revenue ($90.3M vs $80.1M, roughly 1.1× AMERISAFE INC). AMERISAFE INC runs the higher net margin — 10.2% vs 0.1%, a 10.0% gap on every dollar of revenue. On growth, Evolus, Inc. posted the faster year-over-year revenue change (14.4% vs 10.3%). Over the past eight quarters, Evolus, Inc.'s revenue compounded faster (23.4% CAGR vs 2.8%).
AMERISAFE Inc. is a specialty insurance provider that focuses exclusively on workers' compensation coverage for small and mid-sized businesses in high-hazard industries including construction, logging, trucking, and manufacturing. It operates across 49 U.S. states, offering tailored insurance policies paired with targeted risk management support for clients.
Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.
AMSF vs EOLS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $80.1M | $90.3M |
| Net Profit | $8.1M | $130.0K |
| Gross Margin | — | 65.7% |
| Operating Margin | — | 4.7% |
| Net Margin | 10.2% | 0.1% |
| Revenue YoY | 10.3% | 14.4% |
| Net Profit YoY | -9.0% | 101.9% |
| EPS (diluted) | $0.43 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $80.1M | — | ||
| Q4 25 | $81.6M | $90.3M | ||
| Q3 25 | $82.0M | $69.0M | ||
| Q2 25 | $81.1M | $69.4M | ||
| Q1 25 | $72.6M | $68.5M | ||
| Q4 24 | $74.0M | $78.9M | ||
| Q3 24 | $78.7M | $61.1M | ||
| Q2 24 | $75.8M | $66.9M |
| Q1 26 | $8.1M | — | ||
| Q4 25 | $10.4M | $130.0K | ||
| Q3 25 | $13.8M | $-15.7M | ||
| Q2 25 | $14.0M | $-17.1M | ||
| Q1 25 | $8.9M | $-18.9M | ||
| Q4 24 | $13.2M | $-6.8M | ||
| Q3 24 | $14.3M | $-19.2M | ||
| Q2 24 | $11.0M | $-11.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 65.7% | ||
| Q3 25 | — | 66.5% | ||
| Q2 25 | — | 65.3% | ||
| Q1 25 | — | 68.1% | ||
| Q4 24 | — | 66.7% | ||
| Q3 24 | — | 68.9% | ||
| Q2 24 | — | 70.3% |
| Q1 26 | — | — | ||
| Q4 25 | 15.6% | 4.7% | ||
| Q3 25 | 21.3% | -16.7% | ||
| Q2 25 | 21.5% | -14.7% | ||
| Q1 25 | 15.5% | -22.1% | ||
| Q4 24 | 22.7% | -2.9% | ||
| Q3 24 | 22.6% | -25.3% | ||
| Q2 24 | 18.1% | -11.5% |
| Q1 26 | 10.2% | — | ||
| Q4 25 | 12.8% | 0.1% | ||
| Q3 25 | 16.9% | -22.8% | ||
| Q2 25 | 17.2% | -24.7% | ||
| Q1 25 | 12.3% | -27.6% | ||
| Q4 24 | 17.8% | -8.6% | ||
| Q3 24 | 18.2% | -31.4% | ||
| Q2 24 | 14.5% | -17.0% |
| Q1 26 | $0.43 | — | ||
| Q4 25 | $0.55 | $0.01 | ||
| Q3 25 | $0.72 | $-0.24 | ||
| Q2 25 | $0.73 | $-0.27 | ||
| Q1 25 | $0.47 | $-0.30 | ||
| Q4 24 | $0.69 | $-0.11 | ||
| Q3 24 | $0.75 | $-0.30 | ||
| Q2 24 | $0.57 | $-0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.2M | $53.8M |
| Total DebtLower is stronger | — | $146.1M |
| Stockholders' EquityBook value | $246.6M | $-23.1M |
| Total Assets | — | $225.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $34.2M | — | ||
| Q4 25 | $61.9M | $53.8M | ||
| Q3 25 | $54.7M | $43.5M | ||
| Q2 25 | $48.5M | $61.7M | ||
| Q1 25 | $44.8M | $67.9M | ||
| Q4 24 | $44.1M | $87.0M | ||
| Q3 24 | $63.7M | $85.0M | ||
| Q2 24 | $30.6M | $93.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $146.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $121.8M | ||
| Q4 24 | — | $121.5M | ||
| Q3 24 | — | $121.2M | ||
| Q2 24 | — | $120.9M |
| Q1 26 | $246.6M | — | ||
| Q4 25 | $251.6M | $-23.1M | ||
| Q3 25 | $274.8M | $-28.8M | ||
| Q2 25 | $265.6M | $-18.7M | ||
| Q1 25 | $260.8M | $-6.6M | ||
| Q4 24 | $257.3M | $5.5M | ||
| Q3 24 | $314.4M | $5.9M | ||
| Q2 24 | $301.0M | $19.3M |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $225.9M | ||
| Q3 25 | $1.2B | $219.0M | ||
| Q2 25 | $1.2B | $228.8M | ||
| Q1 25 | $1.2B | $213.4M | ||
| Q4 24 | $1.2B | $232.6M | ||
| Q3 24 | $1.3B | $229.6M | ||
| Q2 24 | $1.2B | $233.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 22.00× | ||
| Q3 24 | — | 20.58× | ||
| Q2 24 | — | 6.26× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $12.8M |
| Free Cash FlowOCF − Capex | — | $11.3M |
| FCF MarginFCF / Revenue | — | 12.6% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | — | 98.67× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-45.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $11.1M | $12.8M | ||
| Q3 25 | $10.7M | $-14.7M | ||
| Q2 25 | $-8.4M | $-24.8M | ||
| Q1 25 | $-1.8M | $-15.6M | ||
| Q4 24 | $24.2M | $4.8M | ||
| Q3 24 | $8.4M | $-5.7M | ||
| Q2 24 | $-2.6M | $-6.5M |
| Q1 26 | — | — | ||
| Q4 25 | $8.9M | $11.3M | ||
| Q3 25 | $9.8M | $-15.6M | ||
| Q2 25 | $-9.5M | $-25.5M | ||
| Q1 25 | $-1.8M | $-16.0M | ||
| Q4 24 | $23.4M | $4.4M | ||
| Q3 24 | $8.4M | $-6.0M | ||
| Q2 24 | $-2.6M | $-6.9M |
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | 12.6% | ||
| Q3 25 | 11.9% | -22.7% | ||
| Q2 25 | -11.7% | -36.7% | ||
| Q1 25 | -2.5% | -23.3% | ||
| Q4 24 | 31.5% | 5.5% | ||
| Q3 24 | 10.7% | -9.9% | ||
| Q2 24 | -3.5% | -10.4% |
| Q1 26 | — | — | ||
| Q4 25 | 2.6% | 1.6% | ||
| Q3 25 | 1.1% | 1.4% | ||
| Q2 25 | 1.3% | 1.0% | ||
| Q1 25 | 0.0% | 0.5% | ||
| Q4 24 | 1.1% | 0.6% | ||
| Q3 24 | 0.0% | 0.5% | ||
| Q2 24 | 0.1% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | 1.06× | 98.67× | ||
| Q3 25 | 0.77× | — | ||
| Q2 25 | -0.61× | — | ||
| Q1 25 | -0.20× | — | ||
| Q4 24 | 1.83× | — | ||
| Q3 24 | 0.59× | — | ||
| Q2 24 | -0.24× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
